Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership
Go back to Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.15 +0.14 (3.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.01 | 52 Week High | $45.34 | |||
| Open | $4.00 | 52 Week Low | $15.92 | |||
| Day High | $4.22 | P/E | 1.78 | |||
| Day Low | $3.97 | EPS | $2.33 | |||
| Volume | 556,119 | |||||
